Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)

China flag China · Delayed Price · Currency is CNY
21.01
-0.08 (-0.38%)
Apr 30, 2026, 11:29 AM CST
29.45%
Market Cap 2.37B
Revenue (ttm) 940.19M
Net Income (ttm) -82.39M
Shares Out 112.55M
EPS (ttm) -0.72
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,673,480
Average Volume 1,999,631
Open 21.05
Previous Close 21.09
Day's Range 20.70 - 21.34
52-Week Range 16.20 - 23.52
Beta 0.78
RSI 52.69
Earnings Date Apr 23, 2026

About SHA:605177

Zhejiang East Asia Pharmaceutical Co., Ltd. produces and sells pharmaceutical chemicals, tablets, granules, intermediates, and capsules. It offers quinolones synthetic antibacterial agents, antifungal products, gastrointestinal medications, semi-synthetic cephalosporin antibiotics, carbapenem antibiotics, antiviral agents, central nervous system medications, respiratory drugs, antiallergic agents, antineoplastic agents and tumor adjuvant drugs, and other products. The company provides products in the fields of cardiovascular, anti-aging dementi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 1,749
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 605177
Full Company Profile

Financial Performance

In 2025, SHA:605177's revenue was 940.19 million, a decrease of -21.54% compared to the previous year's 1.20 billion. Losses were -82.39 million, -18.15% less than in 2024.

Financial Statements

News

There is no news available yet.